降糖保肾方对早期糖尿病肾病患者氧化应激的影响(1)
 |
| 第1页 |
参见附件(3373KB，3页)。
[摘要] 目的：研究降糖保肾方对早期糖尿病肾病氧化应激的影响，探讨降糖保肾方治疗早期糖尿病肾病的作用机制。方法：将符合纳入标准的72例患者，随机分为西药组(X组)，中药组(Z组)。分别予厄贝沙坦150 mg/次，1次/d，口服；降糖保肾方(免煎剂)每日2剂，口服；维持治疗8周，观察治疗前后血糖、蛋白尿、血清超氧化物岐化酶(SOD)、过氧化氢酶(CAT)、丙二醛(MDA)变化。结果：治疗8周后，降糖保肾方组空腹血糖显著下降至(8.4±1.0) mmol/L、餐后2 h血糖显著下降至(12.1±1.4) mmol/L、HbA1c显著下降至(8.0±0.3)%(P<0.05)；24 h尿蛋白显著下降至(185.6±17.7) mg，24 h尿微量清蛋白排泄率显著下降至(54.2±7.9) μg/min(P<0.05)；SOD显著升高至(80.0±8.7) nU/ml、CAT显著升高至(26.4±2.4) nU/ml，MDA显著下降至(5.1±0.4) nmol/ml (P<0.05)。结论：降糖保肾方具有抗氧化作用，可能通过抑制氧化应激发挥保护糖尿病肾病的作用。
[关键词] 降糖保肾方；糖尿病肾病；氧化应激；抗氧化
[中图分类号] R587.1 [文献标识码]A[文章编号]1674-4721(2011)08(a)-011-03
The effects of Jiangtangbaoshenfang to patients with early diabetic nephropathy in oxidative stress
XIE Hui1, ZHU Lin2, HUANG Lin2, XIAO Yun1, XIAO Jie1
1.Department of Nephrology, the First Affiliated Hospital of Guangzhou Medical College, Guangdong Province, Guangzhou 510120, China; 2.Department of TCM, the First Affiliated Hospital of Guangzhou Medical College, Guangdong Province, Guangzhou 510120, China
[Abstract] Objective: To study the effects of Jiangtangbaoshenfang to early diabetic nephropathy in oxidative stress and to explore the treating mechanism of Jiangtangbaoshenfang to early diabetic nephropathy. Methods: 72 patients who met the inclusion criteria were randomly divided into western medicine group (X group) and traditional chinese medicine group (Z group). The patients of X group were given oral irbesartan 150 mg per time, one time per day, the patients at Z group were given oral Jiangtangbaoshenfang 2 did per day. The changes of the blood glucose, proteinuria, serum ultra-dismutase (SOD), catalase (CAT), malondialdehyde (MDA) were analyzed before and after 8 weeks treatment. Results: After 8 weeks, Jiangtangbaoshenfang significantly decreased fasting blood glucose to (8.4±1.0) mmol/L, decreased 2 hour postprandial blood glucose to (12.1±1.4) mmol/L, decreased HbA1c to (8.0±0.3)%, decreased 24 hour urine protein to (185.6±17.7) mg, decreased 24 hour urinary albumin excretion rate to (54.2±7.9) μg/min and MDA to (5.1±0.4) nmol/ml (P<0.05); and significantly increased SOD to (80.0±8.7) nU/ml and CAT to (26.4±2.4) nU/ml (P<0.05). Conclusion: Jiangtangbaoshenfang can protect diabetic nephropathy by inhibiting oxidative stress ......
您现在查看是摘要介绍页，详见PDF附件(3373KB，3页)。